Investors

Investors

Company Profile

Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:

 

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events & Presentations
Corporate Presentation
More information is coming soon.
Annual Report and Proxy Statement
Date Title and Summary
Toggle Summary Arena Pharmaceuticals Releases Second Annual Environmental, Social and Governance (ESG) Report
- Company highlights dedication to patients, employees, the community, the environment, and shareholders through initiatives focused on responsibility and sustainability, diversity and inclusion, and patient commitment PARK CITY, Utah --(BUSINESS WIRE)--Apr. 19, 2021-- Arena Pharmaceuticals, Inc.
Toggle Summary Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial During Late-Breaking Research Session at American Academy of Dermatology Virtual Meeting Experience
-Data presentation to be released online at 10:00 AM ET on Friday, April 23, 2021 -Live Q&A session with presenter to be held on Saturday, April 24, 2021 at 3:00 PM ET   PARK CITY, Utah --(BUSINESS WIRE)--Apr. 19, 2021-- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that data from the